ASND icon

Ascendis Pharma
ASND

Overview Fund Activity

182 hedge funds and large institutions have $7.29B invested in Ascendis Pharma in 2022 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 66 increasing their positions, 49 reducing their positions, and 21 closing their positions.

Holders
182
Holders Change
+15
Holders Change %
+8.98%
% of All Funds
3.15%
Holding in Top 10
16
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+6.67%
% of All Funds
0.28%
New
37
Increased
66
Reduced
49
Closed
21
Calls
$225M
Puts
$20.5M
Net Calls
+$204M
Net Calls Change
+$190M

Top Buyers

1
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$792M
2
T. Rowe Price Investment Management
2
T. Rowe Price Investment Management
Maryland
$210M
3
DTC
3
Deep Track Capital
Connecticut
$82.6M
4
ACA
4
Avoro Capital Advisors
New York
$294M
5
Point72 Asset Management
5
Point72 Asset Management
Connecticut
$39.7M

Top Sellers

1
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$400M
2
Goldman Sachs
2
Goldman Sachs
New York
$295M
3
Artisan Partners
3
Artisan Partners
Wisconsin
$738M
4
Assenagon Asset Management
4
Assenagon Asset Management
Luxembourg
$0
5
SCM
5
Spyglass Capital Management
California
$98.1M
Name Market Value Shares Shares
Change 		Shares
Change %
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$792M 7,673,516 +3,812,257 +99%
RCM
2
RA Capital Management
Massachusetts
$781M 7,567,900 – –
Artisan Partners
3
Artisan Partners
Wisconsin
$738M 7,149,493 -323,593 -4%
Fidelity Investments
4
Fidelity Investments
Massachusetts
$545M 5,278,865 -14,255 -0.3%
BBA
5
Baker Bros. Advisors
New York
$501M 4,852,655 – –
T. Rowe Price Associates
6
T. Rowe Price Associates
Maryland
$400M 3,874,863 -1,290,512 -25%
Wellington Management Group
7
Wellington Management Group
Massachusetts
$379M 3,672,226 +123,089 +3%
Westfield Capital Management
8
Westfield Capital Management
Massachusetts
$301M 2,910,724 +122,415 +4%
Goldman Sachs
9
Goldman Sachs
New York
$295M 2,858,430 -457,785 -14%
ACA
10
Avoro Capital Advisors
New York
$294M 2,850,000 +575,000 +25%
T. Rowe Price Investment Management
11
T. Rowe Price Investment Management
Maryland
$210M 2,032,180 +2,032,180 New
Capital International Investors
12
Capital International Investors
California
$136M 1,319,451 +12,430 +1%
EAM
13
Eventide Asset Management
Massachusetts
$124M 1,199,000 – –
Massachusetts Financial Services
14
Massachusetts Financial Services
Massachusetts
$122M 1,184,356 +349,157 +42%
Franklin Resources
15
Franklin Resources
California
$119M 1,154,092 +196,055 +20%
SCM
16
Spyglass Capital Management
California
$98.1M 949,915 -159,755 -14%
DTC
17
Deep Track Capital
Connecticut
$82.6M 800,000 +800,000 New
PI
18
Putnam Investments
Massachusetts
$81.4M 788,065 -15,846 -2%
AllianceBernstein
19
AllianceBernstein
Tennessee
$66.1M 639,876 -43,920 -6%
TCM
20
TimesSquare Capital Management
New York
$66.1M 639,675 +190,025 +42%
Brown Advisory
21
Brown Advisory
Maryland
$65.9M 638,001 -14,723 -2%
Invesco
22
Invesco
Georgia
$62M 600,023 +7,368 +1%
SI
23
Sofinnova Investments
California
$51.6M 499,824 – –
PBA
24
Paradigm Biocapital Advisors
New York
$51.4M 497,347 +65,177 +15%
SEI Investments
25
SEI Investments
Pennsylvania
$48.9M 473,519 +21,718 +5%
1
2 3 4 5